Physician profile
Karen E Muchowski
NPI 1699791178
$748.29
in general payments reported to CMS, 2019-2025
13 companies · $49.19 in 2025
The $49.19 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.98 · 2020: $12.83 · 2021: $120 · 2022: $79.19 · 2023: $107 · 2024: $304 · 2025: $49.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $292.39 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $84.80 | 2019-2024 | Arexvy |
| Abbvie INC. | $71.71 | 2019-2025 | |
| Astellas Pharma US INC | $61.56 | 2024 | Veozah |
| Pfizer INC. | $50.71 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.39 | 2019-2022 | |
| Organon LLC | $37.73 | 2021-2024 | |
| Sanofi Pasteur INC. | $19.95 | 2023 | |
| Amgen INC. | $19.38 | 2023 | Evenity, Prolia |
| Kowa Pharmaceuticals America, INC. | $18.39 | 2022 | |
| Lilly USA, LLC | $18.03 | 2022 | |
| Merck Sharp & Dohme LLC | $16.62 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Muchowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.